Get the Stockscreener App
39.22
1.61%
0.6593
Grail Inc stock is traded at $39.22, with a volume of 440.45K.
It is up +1.61% in the last 24 hours and up +35.85% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
See More
Previous Close:
$38.56
Open:
$40.24
24h Volume:
440.45K
Relative Volume:
0.34
Market Cap:
$1.28B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-0.6479
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
-13.51%
1M Performance:
+35.85%
6M Performance:
+195.48%
1Y Performance:
+0.00%
1-Day Range:
$37.31
$41.11
1-Week Range:
$37.15
$47.25
52-Week Range:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
650-771-9796
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
39.15 | 1.28B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
525.99 | 198.19B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.62 | 148.92B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
128.13 | 36.52B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
440.60 | 35.63B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
188.24 | 33.12B | 15.41B | 1.37B | 2.11B | 7.50 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail goes 'Grey's': Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma
Can This New Cancer Test Detect 70% of Deadly Cancers Before It's Too Late? - StockTitan
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New $244,000 Investment in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Why Grail (GRAL) Is Falling Today - MSN
Grail initiated at equal weight by Morgan Stanley - MSN
Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan
Putting early cancer detection to the test - Nature.com
GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours -February 20, 2025 at 05:36 pm EST - Marketscreener.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges - Investing.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges By Investing.com - Investing.com Nigeria
Grail reports Q4 EPS ($2.89) vs. ($6.04) last year - TipRanks
Earnings call transcript: Grail's Q4 2024 revenue rises, stock surges By Investing.com - Investing.com UK
GRALGrail Inc Latest Stock News & Market Updates - StockTitan
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Earnings Flash (GRAL) GRAIL INC. Posts Q4 Revenue $38.3M, vs. FactSet Est of $34.4M - Marketscreener.com
Can GRAIL's 137,000 Cancer Test Sales Overcome Its $2B Loss? Key Earnings Insights - StockTitan
Grail Inc options imply 13.5% move in share price post-earnings - TipRanks
Golden Grail Beverages Announces Termination of UPDC Beverages Asset Purchase Agreement - GlobeNewswire
Investors Eye Biotech Sector as Cancer Therapy Market Surges - The Globe and Mail
We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate - Yahoo Finance
Grail Inc expected to post a loss of $7.05 a shareEarnings Preview - TradingView
Grail rallies 30% in wake of Quest agreement - MSN
Grail (NASDAQ:GRAL) Trading 5.4% HigherWhat's Next? - MarketBeat
Moloney Securities Asset Management LLC Invests $559,000 in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail shares jump on partnership with Quest Diagnostics - Mugglehead
GRAIL teams up with Quest to widen access to Galleri cancer test - MSN
abrdn plc Purchases Shares of 211,068 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail rallies 30% in wake of Quest agreement (GRAL:NASDAQ) - Seeking Alpha
Grail distribution partnership with Quest a positive, says Guggenheim - TipRanks
Grail and Quest Diagnostics to offer Galleri test to US physicians - Yahoo
Grail (NASDAQ:GRAL) Reaches New 12-Month HighWhat's Next? - MarketBeat
Grail (GRAL) to Release Earnings on Tuesday - MarketBeat
Early Cancer Detection Pioneer GRAIL Sets Crucial Q4 Earnings Release Date - StockTitan
Grail Shares Spiked Wednesday: What's Going On? - Benzinga
Grail and Quest Diagnostics announces initial phase of MCED test program - TipRanks
Why Grail (GRAL) Stock Is Jumping Today - Insider Monkey
GRAIL joins Quest to widen Galleri access (GRAL:NASDAQ) - Seeking Alpha
Grail Makes Cancer Early Detection Test Directly Available to US Physicians Via Quest Diagnostics Collaboration - Marketscreener.com
Grail And Quest Diagnostics Provide Grail's Galleri Multi-Cancer Early Detection (MCED) Test - Marketscreener.com
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.05%
2.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):